Electrolyte Imbalance Analysis at Intensive Care Unit Admission : Retrospective Study

Electrolyte Imbalance Analysis at Icu Admission : Retrospective Study

The type and severity of electrolyte imbalance in patients admitted to the intensive care unit were analyzed.It was evaluated whether these results had an effect on mortality, length of hospital stay, APACHE II scores and ventilator days

Study Overview

• Status: Completed
• Conditions: Electrolyte Imbalance
• Intervention / Treatment: Other: electrolyte imbalance analysis

• Study Type: Observational
• Enrollment (Actual): 824

Contacts and Locations

Study Locations

• Turkey
  • Çankaya
    • Ankara, Çankaya, Turkey
      • Ankara Kecioren Training and Research Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

ıcu patients

Description

Inclusion Criteria: all of the ıcu patients -

Exclusion Criteria:

-

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Retrospective

Number of groups / cohorts

5

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
sodium (hypo-hyper-normonatremia)	Other: electrolyte imbalance analysis; ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance
potassium (hypo-hyper-normokalemia)	Other: electrolyte imbalance analysis; ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance
calcium (hyper-hypo-normocalcemia)	Other: electrolyte imbalance analysis; ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance
magnesium (hyper-hypo-normocalcemia)	Other: electrolyte imbalance analysis; ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance
phosphor (hypo-hyper-normophosphatemia)	Other: electrolyte imbalance analysis; ın this retrospective study we aimed to evaluate the relationship between the ıcu prognosis and the electrolyte imbalance

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The analysis the electrolyte imbalance in ICU and the relationship between the icu prognosis.	Natremia (Hypo: <136 mmol/L, Normo: 136-145 mmol/L, Hyper: >145 mmol/L) Kalemia (Hypo: <3.5 mmol/L, Normo: 3.5-5.5 mmol/L, Hyper: >5.5 mmol/L) Calcemia (Hypo: <8.8 mg/dL, Normo: 8.8-10.6 mg/dL, Hyper: >10.6 mg/dL) Magnesemia (Hypo: <1.9 mg/dL, Normo: 1.9-2.5 mg/dL, Hyper: >2.5 mg/dL) Phosphatemia (Hypo: <2.5 mg/dL, Normo: 2.5-4.5 mg/dL, Hyper: >4.5 mg/dL) The number of patients in all types of electrolyte imbalance will be determined. The effect of the type of electrolyte imbalance on mortality, APACHE-II score and length of invasive ventilation and hospital stay will be evaluated.	2 years

Collaborators and Investigators

• Sponsor: Kecioren Education and Training Hospital

Study record dates

Study Major Dates

• Study Start (Actual): December 10, 2019
• Primary Completion (Actual): April 5, 2021
• Study Completion (Actual): August 15, 2021

Study Registration Dates

• First Submitted: September 2, 2021
• First Submitted That Met QC Criteria: September 19, 2021
• First Posted (Actual): September 22, 2021

Study Record Updates

• Last Update Posted (Actual): September 28, 2021
• Last Update Submitted That Met QC Criteria: September 22, 2021
• Last Verified: September 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: erbil elektrolit

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No